Clinical trial NCT06602180: Scapular PNF and Activity Oriented Antiedema Proprioceptive Therapy on Shoulder Dysfunction Post Matectomy Lymphedema
Official title: Scapular Proprioceptive Neuromuscular Facilitation and Activity Oriented Antiedema Proprioceptive Therapy on Shoulder Dysfunction Post Matectomy Lymphedema
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Upper Limb Edema
Lead sponsor: Cairo University
Sponsor class: OTHER
First posted: 2024-09-19
Enrollment: 93
Sex: FEMALE
Minimum age (years): 40
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Ninety -three female patients suffering from shoulder dysfunction after breast cancer-related arm lymphedema, will National Cancer Institute (Cairo university) be randomly distributed into three groups equal in number.

Detailed description: In this study the patients will be randomly assigned into three groups (Thirty - one patient for each group):

Group (A):

Thirty-one patients will receive: Scapular PNF technique, Activity-Oriented Antiedema Proprioceptive Therapy (TAPA) technique for the affected shoulder region plus conventional physiotherapy program in a form of (Complex decongestive therapy (CDT).

Group (B):

Thirty-one patients will receive Scapular PNF technique for the affected shoulder region plus conventional physiotherapy program in a form of (Complex decongestive therapy (CDT))

Group (C):

Thirty-one patients will receive Activity-Oriented Antiedema Proprioceptive Therapy (TAPA) technique for the affected shoulder region plus conventional physiotherapy program in a form of (Complex decongestive therapy (CDT)

.

Eligibility criteria: Inclusion Criteria:

The subject selection will be according to the following criteria:

* Age range between 40-60 years.
* Only female patients will participate in the study.
* All female patients diagnosed as unilateral breast cancer.
* All Female patients operated on for BC with BCRL in stages I and II.
* All female patients suffering from shoulder dysfunction after breast cancer-related arm lymphedema.
* All patients enrolled to the study will have their informed consent.

Exclusion Criteria:

The potential participants will be excluded if they meet one of the following criteria:

* Patients with health problems, diseases or dysfunctions that prevented them from participating in the intervention.
* Patients with bilateral lymphedema.
* Patients with previous primary lymphedema.
* Patients with metastasis.
* Patients whom staging was not possible due to atypical findings or poor image.
* Patients with active arm infection.

Primary outcomes:
measure: Cone formula for lymphedema assessment
timeFrame: three months
measure: Digital inclinometer for scapular range and shoulder range assessment
timeFrame: three months
measure: Upper limb function/activity performance: Measured with e Quick Disabilities of the Arm, Shoulder and Hand (Quick-DASH):
timeFrame: three months
Secondary outcomes:
Other outcomes:
Locations:
city: Cairo
country: Egypt
facility: Faculty of Physical Therapy
Study officials:
affiliation: Cairo University
name: rasha ahmed, master
role: PRINCIPAL_INVESTIGATOR
References: